Fogacci F, Borghi C, Grassi D, Cicero AFG, People living with human immunodeficiency virus: Cardiovascular risk screening for an early and effective risk management., «ATHEROSCLEROSIS», 2022, 353, pp. 28 - 29 [articolo]
A.F.G. Cicero, M. Salvetti, Peripheral artery disease: A highly prevalent untreated and uncontrolled independent cardiovascular disease., «ATHEROSCLEROSIS», 2022, 354, pp. 55 - 56 [articolo]
Bytyçi I, Penson PE, Mikhailidis DP, Wong ND, Hernandez AV, Sahebkar A, Thompson PD, Mazidi M, Rysz J, Pella D, Reiner Ž, Toth PP, Banach M on behalf of the Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group and the International Lipid Expert Panel (ILEP); Cicero AFG., Prevalence of statin intolerance: a meta-analysis, «EUROPEAN HEART JOURNAL», 2022, 43, pp. 3213 - 3223 [articolo]Open Access
Pagnotta G.; Kalia S.; Di Lisa L.; Cicero A.F.G.; Borghi C.; Focarete M.L., Progress towards 3D bioprinting of tissue models for advanced drug screening: In vitro evaluation of drug toxicity and drug metabolism, «BIOPRINTING», 2022, 27, Article number: e00218, pp. 1 - 16 [articolo]Open Access
Enayati A, Banach M, Jamialahmadi T, Sahebkar A; endorsed by the International Lipid Expert Panel (ILEP) , Cicero AFG, Protective role of nutraceuticals against myocarditis, «BIOMÉDECINE & PHARMACOTHÉRAPIE», 2022, 146, pp. 1 - 11 [articolo]Open Access
Banach M, Catapano AL, Cicero AFG, Escobar C, Foger B, Katsiki N, Latkovskis G, Rakowski M, Reiner Z, Sahebkar A, Sikand G, Penson PE, On Behalf Of The International Lipid Expert Panel Ilep, Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel., «PHARMACOLOGICAL RESEARCH», 2022, 183, Article number: 106370, pp. 1 - 8 [articolo]Open Access
Grassi, G.; Del Pinto, R.; Agabiti Rosei, C.; Agnoletti, D.; Borghi, C.; Cicero, A. F. G.; De Ciuceis, C.; Desideri, G.; Grassi, D.; Muiesan, M. L.; Paini, A.; Salvetti, M.; Tocci, G.; Veglio, F.; Volpe, M.; Ferri, C., Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension, «HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION», 2022, 29, pp. 105 - 113 [articolo]Open Access
Fogacci F., Cicero A.F.G., Reply - Seek methodological rigor & beware of imitations, «CLINICAL NUTRITION», 2022, 41, pp. 1854 - 1854 [articolo]
Fogacci F, Gori D, Cicero AFG, Representativity of women and racial/ethnic minorities in randomized clinical trials on bempedoic acid: Positive efforts and lacking data, «EUROPEAN JOURNAL OF INTERNAL MEDICINE», 2022, 96, pp. 122 - 123 [articolo]
Cicero, A. F. G.; Cincione, I. R., Secondary (acquired) hypercholesterolemia, in: Cholesterol: From Chemistry and Biophysics to the Clinic, Rotterdam, Elsevier, 2022, pp. 609 - 621 [capitolo di libro]
Masulli M, D'Elia L, Angeli F, Barbagallo CM, Bilancio G, Bombelli M, Bruno B, Casiglia E, Cianci R, Cicero AFG, Cirillo M, Cirillo P, Dell'Oro R, Desideri G, Ferri C, Gesualdo L, Giannattasio C, Grassi G, Iaccarino G, Lippa L, Mallamaci F, Maloberti A, Masi S, Mazza A, Mengozzi A, Muiesan ML, Nazzaro P, Palatini P, Parati G, Pontremoli R, Quarti-Trevano F, Rattazzi M, Reboldi G, Rivasi G, Salvetti M, Tikhonoff V, Tocci G, Ungar A, Verdecchia P, Viazzi F, Virdis A, Volpe M, Borghi C, Galletti F; from the Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension, Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project, «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2022, 32, pp. 1245 - 1252 [articolo]
Imbalzano E, Russo GT, Giandalia A, Sciacqua A, Orlando L, Russo V, Perticone M, Cicero AFG, Versace AG, Di Micco P, Ciconte VA, Dattilo G, Squadrito G, Vatrano M., Sex-Specific Impact of Different Obesity/Metabolic Phenotypes on Long-Term Cardiovascular Outcomes in Acute Coronary Syndrome Patients, «BIOMEDICINES», 2022, 10, Article number: 424, pp. 1 - 18 [articolo]Open Access
Fogacci F, Borghi C, Tocci G, Cicero AFG, Socioeconomic status as determinant of individual cardiovascular risk, «ATHEROSCLEROSIS», 2022, 346, pp. 82 - 83 [articolo]
Penson P E, Bruckert E, Marais D, Reiner Ž, Pirro M, Sahebkar A, Bajraktari G, Mirrakhimov E, Rizzo M , Mikhailidis DP, Sachinidis A,Gaita D, Gustavs Latkovskis G, Mazidi M, Toth PP, Pella D, Alnouri F, Postadzhiyan A, Yeh H, John Mancini GBJ, von Haehling S, Banac M, International Lipid Expert Panel (ILEP), Cicero AFG, Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP), «JOURNAL OF CACHEXIA, SARCOPENIA AND MUSCLE», 2022, 13, pp. 1596 - 1622 [articolo]Open Access
Colosimo, S.; Balzani, E.; Cioni, R. M.; Campesato, M.; Cicero, A. F. G., Supplementation with Anti-inflammatory Nutraceutical Products in the Management of Chronic Pelvic Pain: A Narrative Review, «CURRENT TOPICS IN NUTRACEUTICALS RESEARCH», 2022, 20, pp. 265 - 275 [articolo]
